Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Catalyst. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel oxidative esterification method using metalloporphyrins offers high selectivity and mild conditions for efficient carboxylic acid ester manufacturing.
Patent CN115894525A reveals a novel cyclization method yielding >99.9% purity intermediates, offering significant cost and supply chain advantages for global pharma manufacturers.
Patent CN105061126B reveals water-based rhodium catalysis for high-purity pharmaceutical intermediates. Achieve significant cost reduction and supply chain reliability.
Patent CN109651327B details a novel catalyst-free oxidation of xanthene to xanthone. This method offers high purity, reduced waste, and scalable manufacturing for pharmaceutical intermediates.
Patent CN117299207A reveals novel supported catalyst for GalNAc intermediate synthesis offering higher yield and safer scalable production for pharmaceutical supply chains.
Patent CN101307011B details binary catalyst systems enhancing selectivity and purity for N-ethyl-N-cyanoethylaniline production offering significant supply chain stability
Novel patent CN103396362B offers high-yield synthesis. Reduces pollution and cost for pharmaceutical intermediates manufacturing. Reliable supply chain solutions for global buyers.
Patent CN105085228B details a low-corrosion oxidation process for 3-5-dimethylbenzoic acid offering significant cost reduction in fine chemical manufacturing and enhanced supply chain reliability.
Patent CN111635363A reveals a solvent-free ball-milling route for N,N'-disubstituted benzimidazolium salts, offering high purity and reduced lead time for pharmaceutical intermediate manufacturing.
Novel chiral phosphonous bis-amino-oxazoline copper complex enables 98% yield in Henry reactions, offering reliable pharmaceutical intermediate supply.
Patent CN102728407B details a waste-utilizing synthesis for chiral salen catalysts, offering cost reduction in pharmaceutical intermediate manufacturing via single-solvent processes.
Patent CN113149865B reveals a metal-free mPMF catalyst for efficient ethyl α-cyanocinnamate production, offering superior selectivity and cost reduction in pharma intermediate manufacturing.
Patent CN118530280A details novel palladium ligands for acrylate synthesis offering high selectivity and supply chain stability for global pharmaceutical manufacturers.
Patent CN109535080B reveals a green catalytic route for benzimidazole derivatives, offering high yields and simplified purification for global supply chains.
Discover the novel synthesis of (-)-2-(4'-pyridyl)-4,5-pinene-pyridine hexafluoroacetylacetonate copper complex. A reliable supplier for high-purity chiral functional materials with ferromagnetic properties.
Patent CN101659642B details a novel phase-transfer catalytic route for sulfonylureas, offering safer agrochemical manufacturing and significant cost reduction.
Novel fluorine-containing diaryliodonium salts enable mild arylation. Efficient synthesis reduces costs for pharmaceutical intermediate manufacturing.
Novel Ti-Si catalyst for DPC synthesis via transesterification. High stability, >60% conversion. Cost-effective pharma/polymer intermediate solution.
Patent CN100534995C reveals high-yield synthesis. Enhances supply chain reliability and purity for industrial catalysts and pharmaceutical intermediates globally.
Patent CN110590658A reveals a novel manganese catalyst for hydrogenation, offering cost reduction and high purity for pharmaceutical intermediate manufacturing supply chains.